Background and objective: Urological infections significantly impact the wellbeing and quality of life of individuals owing to their widespread occurrence and diverse clinical manifestations. The objective of the guidelines panel was to provide evidence-based guidance on the diagnosis, treatment, and prevention of urinary tract infections (UTIs) and male accessory-gland infections, while addressing crucial public health aspects related to infection control and antimicrobial stewardship. 

Methods: For the 2024 guidelines on urological infections, new and relevant evidence was identified, collated, and appraised via a structured assessment of the literature. Databases searched included Medline, EMBASE, and the Cochrane Libraries. Recommendations within the guidelines were developed by the panel to prioritise clinically important care decisions. The strength of each recommendation was determined according to a balance between desirable and undesirable consequences of alternative management strategies, the quality of the evidence (including the certainty of estimates), and the nature and variability of patient values and preferences. 

Key findings and limitations: Key recommendations emphasise the importance of a thorough medical history and physical examination for patients with urological infections. The guidelines stress the role of antimicrobial stewardship to combat the rising threat of antimicrobial resistance, providing recommendations for antibiotic selection, dosing, and duration on the basis of the latest evidence.

背景和目的：泌尿系统感染显著影响健康和由于其广泛发生和不同的临床特征，个体的生活质量表现。指南小组的目的是提供基于证据的尿路感染 (UTI) 的诊断、治疗和预防指南和男性副腺感染，同时解决关键的公共卫生方面与感染控制和抗菌药物管理相关。

方法：对于2024年泌尿外科感染指南，新的和相关的证据通过文献的结构化评估进行识别、整理和评价。检索的数据库包括Medline、EMBASE和Cochrane Libraries。指南中的建议由小组制定，以优先考虑临床重要的护理决策。确定了每项建议的强度根据替代方案的预期和非预期结果之间的平衡管理策略、证据质量（包括估计值的确定性）以及患者价值观和偏好的性质和变异性。

关键发现和局限性：关键建议强调了对泌尿系统感染患者进行全面病史和体格检查的重要性。该指南强调了抗菌剂管理在对抗不断上升的威胁中的作用的抗菌药物耐药性，为抗生素选择、给药提供建议，和基于最新证据的持续时间。